Aprea Therapeutics, Inc. (APRE): auditor change — Aprea Therapeutics dismisses EY, appoints EisnerAmper as new independent auditor

Aprea Therapeutics, Inc.

On April 17, 2023, Aprea dismissed Ernst & Young LLP as its independent auditor, effective immediately.
The Audit Committee approved the dismissal and engagement of EisnerAmper LLP as new auditor for FY 2023.
EY's reports for 2022 and 2021 contained no adverse opinion or qualification; no disagreements or reportable events existed.
No consultations with EisnerAmper occurred prior to engagement on any accounting matters.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aprea Therapeutics, Inc. dismissed Ernst & Young LLP as its auditor.

Action: dismissal
Auditor: Ernst & Young LLP
Successor: EisnerAmper LLP

Exact text from the filing

On April 17, 2023, Aprea Therapeutics, Inc. (the “Company”) dismissed Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aprea Therapeutics, Inc. engaged EisnerAmper LLP as its auditor.

Action: engagement
Auditor: EisnerAmper LLP

Exact text from the filing

On April 17, 2023, in connection with the Company’s dismissal of EY, the Company engaged EisnerAmper LLP (“EisnerAmper”) as its new independent registered public accounting firm to audit the Company’s financial statements for the year ending December 31, 2023.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

Aprea Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-046719

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.